Bifidenone

ID: ALA4083202

PubChem CID: 126508539

Max Phase: Preclinical

Molecular Formula: C21H26O5

Molecular Weight: 358.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC[C@H]1C[C@]2([C@@H](C)Cc3ccc(OC)c(OC)c3)OCOC2=CC1=O

Standard InChI:  InChI=1S/C21H26O5/c1-5-6-16-12-21(20(11-17(16)22)25-13-26-21)14(2)9-15-7-8-18(23-3)19(10-15)24-4/h5,7-8,10-11,14,16H,1,6,9,12-13H2,2-4H3/t14-,16-,21+/m0/s1

Standard InChI Key:  BHTLRQBVGVBCSE-WDUKFBBWSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    9.8930  -13.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8930  -13.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6024  -14.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3077  -13.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6024  -12.7573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3069  -13.1643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9159  -12.6202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5852  -11.8725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7719  -11.9574    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8847  -12.3445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8818  -11.5232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1743  -12.7598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4611  -12.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1817  -14.4051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4693  -13.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7581  -14.4071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6024  -15.2212    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4611  -11.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7487  -11.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0373  -11.5332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0429  -12.3587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7559  -12.7652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3339  -12.7764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3235  -11.1281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6192  -12.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3195  -10.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  2  3  1  0
  3  4  1  0
  4  6  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  5  9  1  6
  5 10  1  0
 10 11  1  6
 10 12  1  0
 12 13  1  0
  2 14  1  1
 14 15  1  0
 15 16  2  0
  3 17  2  0
 13 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 13  1  0
 21 23  1  0
 20 24  1  0
 23 25  1  0
 24 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4083202

    ---

Associated Targets(Human)

HCC 2998 (41480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Malme-3M (44254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI/ADR-RES (33767 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 358.43Molecular Weight (Monoisotopic): 358.1780AlogP: 3.67#Rotatable Bonds: 7
Polar Surface Area: 53.99Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.84CX LogD: 3.84
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: 1.35

References

1. Williams RB, Martin SM, Lawrence JA, Norman VL, O'Neil-Johnson M, Eldridge GR, Starks CM..  (2017)  Isolation and Identification of the Novel Tubulin Polymerization Inhibitor Bifidenone.,  80  (3): [PMID:28335606] [10.1021/acs.jnatprod.6b00893]
2. Huang Z, Williams RB, Martin SM, Lawrence JA, Norman VL, O'Neil-Johnson M, Harding J, Mangette JE, Liu S, Guzzo PR, Starks CM, Eldridge GR..  (2018)  Bifidenone: Structure-Activity Relationship and Advanced Preclinical Candidate.,  61  (15): [PMID:29995409] [10.1021/acs.jmedchem.7b01644]

Source